These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24507090)

  • 1. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: population-based cohort study with 6-year follow-up.
    Mäntyselkä P; Niskanen L; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Lipids Health Dis; 2014 Feb; 13():28. PubMed ID: 24507090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study.
    Choo J; Ueshima H; Curb JD; Shin C; Evans RW; El-Saed A; Kadowaki T; Okamura T; Nakata K; Otake T; Miura K; Abbott RD; Sutton-Tyrrell K; Edmundowicz D; Kuller LH; Sekikawa A;
    Am J Clin Nutr; 2010 May; 91(5):1195-203. PubMed ID: 20357040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
    Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
    Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice weekly intake of farmed Atlantic salmon (Salmo salar) positively influences lipoprotein concentration and particle size in overweight men and women.
    Raatz SK; Johnson LK; Rosenberger TA; Picklo MJ
    Nutr Res; 2016 Sep; 36(9):899-906. PubMed ID: 27632909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up.
    Mäntyselkä P; Kautiainen H; Saltevo J; Würtz P; Soininen P; Kangas AJ; Ala-Korpela M; Vanhala M
    Atherosclerosis; 2012 Jul; 223(1):239-43. PubMed ID: 22658258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level and lipoprotein particle size.
    Hämäläinen P; Saltevo J; Kautiainen H; Mäntyselkä P; Vanhala M
    Lipids Health Dis; 2018 Jan; 17(1):10. PubMed ID: 29321013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted fatty acid distribution in HDL and LDL according to apolipoprotein E allele.
    Dang TM; Conway V; Plourde M
    Nutrition; 2015 Jun; 31(6):807-12. PubMed ID: 25933487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study.
    Griffin MD; Sanders TA; Davies IG; Morgan LM; Millward DJ; Lewis F; Slaughter S; Cooper JA; Miller GJ; Griffin BA
    Am J Clin Nutr; 2006 Dec; 84(6):1290-8. PubMed ID: 17158408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK; Glasser SP; Oberman A; Kabagambe EK; Hopkins PN; Tsai MY; Straka RJ; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Oct; 10():181. PubMed ID: 22008512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subfractions and dietary intake of n-3 fatty acid: the Genetics of Coronary Artery Disease in Alaska Natives study.
    Annuzzi G; Rivellese AA; Wang H; Patti L; Vaccaro O; Riccardi G; Ebbesson SO; Comuzzie AG; Umans JG; Howard BV
    Am J Clin Nutr; 2012 Jun; 95(6):1315-22. PubMed ID: 22572646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis.
    Siddiqui MS; Van Natta ML; Connelly MA; Vuppalanchi R; Neuschwander-Tetri BA; Tonascia J; Guy C; Loomba R; Dasarathy S; Wattacheril J; Chalasani N; Sanyal AJ;
    J Hepatol; 2020 Jan; 72(1):25-33. PubMed ID: 31634532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women.
    Kasim-Karakas SE; Lane E; Almario R; Mueller W; Walzem R
    Metabolism; 1997 Apr; 46(4):431-6. PubMed ID: 9109849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
    Deeg MA; Buse JB; Goldberg RB; Kendall DM; Zagar AJ; Jacober SJ; Khan MA; Perez AT; Tan MH;
    Diabetes Care; 2007 Oct; 30(10):2458-64. PubMed ID: 17595355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.
    Wood AC; Glasser S; Garvey WT; Kabagambe EK; Borecki IB; Tiwari HK; Tsai MY; Hopkins PN; Ordovas JM; Arnett DK
    Lipids Health Dis; 2011 Aug; 10():143. PubMed ID: 21854610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.